Further, we identified that CRC patients without lymph node metastasis had better five-year survival rate and median survival time in comparison with the lymph node metastasis regardless the tumor size, clinicopathologic stage and sPD-L1 level. Here, SPDL1 is linked to metastatic malignant neoplasm in the lymph nodes.